Arwan Pharmaceutical Industries, Lebanon

arwanlb.com

Arwan Pharmaceutical Industries,are one of the most advanced biotech manufacturing facilities in the MENA and Africa. Our ultimate goal is to secure quality critical care medicine to all patients who need them. Thus, quality is embedded in each and every step of our operations, from the buildings, machineries, materials, methods and manpower. Empowered by our passion for achievement, strong belief in our capabilities, and the emphasis on performance with integrity, we continue to work according to our motto:

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

GOODRX CLOSES ACQUISITION OF VITACARE, A TECH-ENABLED PHARMACY SERVICES PLATFORM

GoodRx | April 18, 2022

news image

GoodRx, a leading consumer-focused digital healthcare platform announced the completion of its previously announced acquisition of vitaCare for $150 million in cash, with an additional $7 million of consideration contingent payment upon vitaCare’s financial performance through 2023. VitaCare is a pharmacy services platform that expands GoodRx’s offering to pharmaceutical manufacturers while helping to improve patient access and adherence to affordable brand drugs. The acquisition wil...

Read More

PHARMA TECH

IDBS ANNOUNCES DATA MANAGEMENT PARTNERSHIP WITH PHARMAESSENTIA INNOVATION RESEARCH CENTER

PR Newswire | January 24, 2024

news image

IDBS announced today that it has entered into a partnership with Massachusetts-based PharmaEssentia Innovation Research Center (PIRC) on its Polar platform to help digitize data management and facilitate collaboration between the company's global research and development (R&D) teams. The Polar platform will provide PIRC, the newly established U.S. hub of PharmaEssentia's R&D efforts, the ability to electronically collaborate with its team headquartered in Taipei,...

Read More

GLOBAL OXYMETAZOLINE MARKET 2020 – COMPLEX PHARMACEUTICAL, ALLERGAN, ALTAIRE PHARMACEUTICALS, HEALTH LIFE OF USA

bccourier | April 16, 2020

news image

Global Oxymetazoline Market research report delivers the analysis of the market outlook, framework, and socio-economic impacts. This report tries to covers the authenticate information of the market size, share, product footprint, revenue, and progress rate. All this information driven by primary and secondary researches, with reliable and authentic projections regarding the technical jargon. This study assesses the current landscape of the ever-evolving business sector and the present and futur...

Read More

Pharma Tech

BAYER AND MAMMOTH BIOSCIENCES TO COLLABORATE ON NOVEL GENE EDITING TECHNOLOGY

Bayer and Mammoth Biosciences | January 10, 2022

news image

Bayer AG and Mammoth Biosciences, Inc., which is harnessing the diversity of nature to power the next-generation CRISPR products, announced a strategic collaboration and option agreement for the use of Mammoth’s CRISPR systems to develop in vivo gene-editing therapies. Mammoth Biosciences’ groundbreaking gene-editing technology is a key enabling technology, as well as a stand-alone therapeutic modality. It will significantly enhance Bayer’s efforts to develop tra...

Read More
news image

Business Insights

GOODRX CLOSES ACQUISITION OF VITACARE, A TECH-ENABLED PHARMACY SERVICES PLATFORM

GoodRx | April 18, 2022

GoodRx, a leading consumer-focused digital healthcare platform announced the completion of its previously announced acquisition of vitaCare for $150 million in cash, with an additional $7 million of consideration contingent payment upon vitaCare’s financial performance through 2023. VitaCare is a pharmacy services platform that expands GoodRx’s offering to pharmaceutical manufacturers while helping to improve patient access and adherence to affordable brand drugs. The acquisition wil...

Read More
news image

PHARMA TECH

IDBS ANNOUNCES DATA MANAGEMENT PARTNERSHIP WITH PHARMAESSENTIA INNOVATION RESEARCH CENTER

PR Newswire | January 24, 2024

IDBS announced today that it has entered into a partnership with Massachusetts-based PharmaEssentia Innovation Research Center (PIRC) on its Polar platform to help digitize data management and facilitate collaboration between the company's global research and development (R&D) teams. The Polar platform will provide PIRC, the newly established U.S. hub of PharmaEssentia's R&D efforts, the ability to electronically collaborate with its team headquartered in Taipei,...

Read More
news image

GLOBAL OXYMETAZOLINE MARKET 2020 – COMPLEX PHARMACEUTICAL, ALLERGAN, ALTAIRE PHARMACEUTICALS, HEALTH LIFE OF USA

bccourier | April 16, 2020

Global Oxymetazoline Market research report delivers the analysis of the market outlook, framework, and socio-economic impacts. This report tries to covers the authenticate information of the market size, share, product footprint, revenue, and progress rate. All this information driven by primary and secondary researches, with reliable and authentic projections regarding the technical jargon. This study assesses the current landscape of the ever-evolving business sector and the present and futur...

Read More
news image

Pharma Tech

BAYER AND MAMMOTH BIOSCIENCES TO COLLABORATE ON NOVEL GENE EDITING TECHNOLOGY

Bayer and Mammoth Biosciences | January 10, 2022

Bayer AG and Mammoth Biosciences, Inc., which is harnessing the diversity of nature to power the next-generation CRISPR products, announced a strategic collaboration and option agreement for the use of Mammoth’s CRISPR systems to develop in vivo gene-editing therapies. Mammoth Biosciences’ groundbreaking gene-editing technology is a key enabling technology, as well as a stand-alone therapeutic modality. It will significantly enhance Bayer’s efforts to develop tra...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us